The global intravenous equipment market size is predicted to increase from USD 22.59 billion in 2024, grew to USD 23.94 billion in 2025 and is anticipated to reach around USD 40.41 billion by 2034, poised to grow at a CAGR of 5.99% between 2024 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Intravenous Equipment Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Intravenous Equipment Market Revenue and Volume, by Type, 2024-2034
8.1.1. IV Catheters
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. IV Tubing Sets
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. IV Fluids
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. IV Pumps
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
8.1.5. Cannula
8.1.5.1. Market Revenue and Volume Forecast (2021-2034)
8.1.6. Hypodermic needles
8.1.6.1. Market Revenue and Volume Forecast (2021-2034)
8.1.7. Stopcock
8.1.7.1. Market Revenue and Volume Forecast (2021-2034)
8.1.8. Needless Connector
8.1.8.1. Market Revenue and Volume Forecast (2021-2034)
8.1.9. Drip chamber
8.1.9.1. Market Revenue and Volume Forecast (2021-2034)
8.1.10. Securement Device
8.1.10.1. Market Revenue and Volume Forecast (2021-2034)
8.1.11. Tourniquet
8.1.11.1. Market Revenue and Volume Forecast (2021-2034)
8.1.12. Other
8.1.12.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Intravenous Equipment Market Revenue and Volume, by End-User, 2024-2034
9.1.1. Hospitals
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Clinics
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Home Care Settings
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
9.1.4. Others
9.1.4.1. Market Revenue and Volume Forecast (2021-2034)
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.1.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.1.3.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.1.4.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.2.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.2.3.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.2.4.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.2.5.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.2.6.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.3.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.3.3.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.3.4.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.3.5.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.3.6.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.4.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.4.3.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.4.4.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.4.5.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.4.6.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.5.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.5.3.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.5.4.2. Market Revenue and Volume Forecast, by End-User (2021-2034)
11.1. Becton, Dickinson and Company
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. B. Braun Melsungen AG
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Smiths Medical
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. ICU Medical, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Baxter International Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Fresenius Kabi AG
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Hospira, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Nipro Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. DexTech Medical
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Enduropacks, Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample